Neuronetics, Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $149.2M | $74.9M | $71.3M | $65.2M | $55.3M | $49.2M | $62.7M |
| Cost of Revenue | — | $76.8M | $20.7M | $19.6M | $15.5M | $11.7M | $11.6M | $15.4M |
| Gross Profit | — | $72.3M | $54.2M | $51.7M | $49.7M | $43.7M | $37.7M | $47.3M |
| Gross Margin | — | 48.5% | 72.3% | 72.5% | 76.3% | 78.9% | 76.5% | 75.4% |
| Operating Expenses | ||||||||
| Research & Development | — | $6.6M | $12.8M | $9.5M | $9.3M | $7.9M | $9.2M | $13.7M |
| SG&A Expense | — | $49.7M | $30.3M | $25.4M | $25.5M | $25.6M | $18.2M | $17.5M |
| Operating Income | — | $-31.4M | $-34.6M | $-30.6M | $-35.1M | $-27.6M | $-22.3M | $-26.9M |
| Operating Margin | — | -21.1% | -46.2% | -42.8% | -53.8% | -49.8% | -45.3% | -43.0% |
| Interest Expense | — | $7.6M | $7.3M | $5.4M | $4.3M | $4.0M | $4.5M | $3.7M |
| Pretax Income | — | — | — | — | — | — | — | $-29.0M |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-39.0M | $-43.7M | $-30.2M | $-37.2M | $-31.2M | $-27.5M | $-29.0M |
| Net Margin | — | -26.1% | -58.4% | -42.3% | -57.0% | -56.4% | -55.7% | -46.4% |
| EPS (Basic) | — | $-0.59 | $-0.69 | $-0.53 | $-0.69 | $-0.61 | $-0.73 | $-0.79 |
| EPS (Diluted) | — | $-0.59 | $-0.69 | $-0.53 | $-0.69 | $-0.61 | $-0.73 | $-0.79 |
| Shares Outstanding (Basic) | 69.3M | 66.0M | 63.5M | 57.3M | 53.8M | 51.0M | 37.7M | 36.8M |
| Shares Outstanding (Diluted) | 69.3M | 66.0M | 63.5M | 57.3M | 53.8M | 51.0M | 37.7M | 36.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |